|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chansky K, Detterbeck FC, Nicholson AG,
Rusch VW, Vallières E, Groome P, Kennedy C, Krasnik M, Peake M,
Shemanski L, et al: The IASLC lung cancer staging project: External
validation of the revision of the TNM stage groupings in the eighth
edition of the TNM classification of lung cancer. J Thorac Oncol.
12:1109–1121. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang C, Wu Y, Shao J, Liu D and Li W:
Clinicopathological variables influencing overall survival,
recurrence and post-recurrence survival in resected stage I
non-small-cell lung cancer. BMC Cancer. 20:1502020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang X, Chen Y, Wang X, Tian H, Wang Y,
Jin J, Shan Z, Liu Y, Cai Z, Tong X, et al: Stem cell factor SOX2
confers ferroptosis resistance in lung cancer via upregulation of
SLC7A11. Cancer Res. 81:5217–5229. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Clara JA, Monge C, Yang Y and Takebe N:
Targeting signalling pathways and the immune microenvironment of
cancer stem cells-a clinical update. Nat Rev Clin Oncol.
17:204–232. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schaal CM, Bora-Singhal N, Kumar DM and
Chellappan SP: Regulation of Sox2 and stemness by nicotine and
electronic-cigarettes in non-small cell lung cancer. Mol Cancer.
17:1492018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sunayama J, Matsuda K, Sato A, Tachibana
K, Suzuki K, Narita Y, Shibui S, Sakurada K, Kayama T, Tomiyama A
and Kitanaka C: Crosstalk between the PI3K/mTOR and MEK/ERK
pathways involved in the maintenance of self-renewal and
tumorigenicity of glioblastoma stem-like cells. Stem Cells.
28:1930–1939. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nimmakayala RK, Leon F, Rachagani S, Rauth
S, Nallasamy P, Marimuthu S, Shailendra GK, Chhonker YS, Chugh S,
Chirravuri R, et al: Metabolic programming of distinct cancer stem
cells promotes metastasis of pancreatic ductal adenocarcinoma.
Oncogene. 40:215–231. 202 View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sharif T, Martell E, Dai C, Singh SK and
Gujar S: Regulation of the proline regulatory axis and autophagy
modulates stemness in TP73/p73 deficient cancer stem-like cells.
Autophagy. 15:934–936. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaufhold S, Garbán H and Bonavida B: Yin
Yang 1 is associated with cancer stem cell transcription factors
(SOX2, OCT4, BMI1) and clinical implication. J Exp Clin Cancer Res.
35:842016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Walcher L, Kistenmacher AK, Suo H, Kitte
R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S and
Kossatz-Boehlert U: Cancer stem cells-Origins and biomarkers:
Perspectives for targeted personalized therapies. Front Immunol.
11:12802020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fu Z, Cao X, Yang Y, Song Z, Zhang J and
Wang Z: Upregulation of FoxM1 by MnSOD overexpression contributes
to cancer Stem-like cell characteristics in the lung cancer H460
cell line. Technol Cancer Res Treat. 17:15330338187896352018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu F, Cao X, Liu Z, Guo H, Ren K, Quan M,
Zhou Y, Xiang H and Cao J: Casticin suppresses self-renewal and
invasion of lung cancer stem-like cells from A549 cells through
down-regulation of pAkt. Acta Biochim Biophys Sin (Shanghai).
46:15–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei D, Yang L, Lv B and Chen L: Genistein
suppresses retinoblastoma cell viability and growth and induces
apoptosis by upregulating miR-145 and inhibiting its target ABCE1.
Mol Vis. 23:385–394. 2017.PubMed/NCBI
|
|
15
|
Ma CH, Zhang YX, Tang LH, Yang XJ, Cui WM,
Han CC and Ji WY: MicroRNA-1469, a p53-responsive microRNA promotes
Genistein induced apoptosis by targeting Mcl1 in human laryngeal
cancer cells. Biomed Pharmacother. 106:665–671. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang L, Zhang J, Gong Y and Lv L:
Systematic and experimental investigations of the anti-colorectal
cancer mediated by genistein. Biofactors. 46:974–982. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ning Y, Xu M, Cao X, Chen X and Luo X:
Inactivation of AKT, ERK and NF-κB by genistein derivative,
7-difluoromethoxyl-5,4′-di-n-octylygenistein, reduces ovarian
carcinoma oncogenicity. Oncol Rep. 38:949–958. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiang HL, Liu F, Quan MF, Cao JG and Lv Y:
7-difluoromethoxyl-5,4′-di-n-octyl genistein inhibits growth of
gastric cancer cells through down-regulating forkhead box M1. World
J Gastroenterol. 18:4618–4626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ren W, Hou J, Yang C, Wang H, Wu S, Wu Y,
Zhao X and Lu C: Extracellular vesicles secreted by hypoxia
pre-challenged mesenchymal stem cells promote non-small cell lung
cancer cell growth and mobility as well as macrophage M2
polarization via miR-21-5p delivery. J Exp Clin Cancer Res.
38:622019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li P, Xing W, Xu J, Yuan D, Liang G, Liu B
and Ma H: microRNA-301b-3p downregulation underlies a novel
inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell
lung cancer. Stem Cell Res Ther. 10:1442019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie C, Zhu J, Jiang Y, Chen J, Wang X,
Geng S, Wu J, Zhong C, Li X and Meng Z: Sulforaphane inhibits the
acquisition of tobacco Smoke-induced lung cancer stem cell-like
properties via the IL-6/ΔNp63α/Notch axis. Theranostics.
9:4827–4840. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lai SW, Chen MY, Bamodu OA, Hsieh MS,
Huang TY, Yeh CT, Lee WH and Cherng YG: Exosomal lncRNA PVT1/VEGFA
axis promotes colon cancer metastasis and stemness by
downregulation of tumor suppressor miR-152-3p. Oxid Med Cell
Longev. 2021:99598072021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang CF, Xie YX, Qian YC, Wang M, Liu LZ,
Shu YQ, Bai XM and Jiang BH: TBX15/miR-152/KIF2C pathway regulates
breast cancer doxorubicin resistance via promoting PKM2
ubiquitination. Cancer Cell Int. 21:5422021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moya L, Meijer J, Schubert S, Matin F and
Batra J: Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289
expression as biomarker for prostate cancer diagnosis. Int J Mol
Sci. 20:11542019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lyu M, Li X, Shen Y, Lu J, Zhang L, Zhong
S and Wang J: CircATRNL1 and circZNF608 inhibit ovarian cancer by
sequestering miR-152-5p and encoding protein. Front Genet.
13:7840892022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yuan Q, Wang R, Li X, Sun F, Lin J, Fu Z
and Zhang J: DNMT1/miR-152-3p/SOS1 signaling axis promotes
self-renewal and tumor growth of cancer stem-like cells derived
from non-small cell lung cancer. Clin Epigenetics. 16:552024.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao L, Wu X, Zhang Z, Fang L, Yang B and
Li Y: ELF1 suppresses autophagy to reduce cisplatin resistance via
the miR-152-3p/NCAM1/ERK axis in lung cancer cells. Cancer Sci.
114:2650–2663. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang J, Lou J, Liu X and Xie Y: LncRNA
PCGsEM1 contributes to the proliferation, migration and invasion of
Non-small cell lung cancer cells via acting as a sponge for
miR-152-3p. Curr Pharm Des. 27:4663–4670. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang R, Wang S, Wang N, Zheng Y, Zhou J,
Yang B, Wang X, Zhang J, Guo L, Wang S, et al: CCL5 derived from
tumor-associated macrophages promotes prostate cancer stem cells
and metastasis via activating β-catenin/STAT3 signaling. Cell Death
Dis. 11:2342020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ouyang S, Li H, Lou L, Huang Q, Zhang Z,
Mo J, Li M, Lu J, Zhu K, Chu Y, et al: Inhibition of
STAT3-ferroptosis negative regulatory axis suppresses tumor growth
and alleviates chemoresistance in gastric cancer. Redox Biol.
52:1023172022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cao Y, Shi H, Ren F, Jia Y and Zhang R:
Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in
epithelial ovarian cancer. Exp Cell Res. 359:185–194. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Al-Harbi B and Aboussekhra A: Cucurbitacin
I (JSI-124)-dependent inhibition of STAT3 permanently suppresses
the pro-carcinogenic effects of active breast cancer-associated
fibroblasts. Mol Carcinog. 60:242–251. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li X, Wang L, Cao X, Zhou L, Xu C, Cui Y,
Qiu Y and Cao J: Casticin inhibits stemness of hepatocellular
carcinoma cells via disrupting the reciprocal negative regulation
between DNMT1 and miR-148a-3p. Toxicol Appl Pharmacol.
396:1149982020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen MJ, Cheng YM, Chen CC, Chen YC and
Shen CJ: MiR-148a and miR-152 reduce tamoxifen resistance in ER+
breast cancer via downregulating ALCAM. Biochem Biophys Res Commun.
483:840–846. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He WW, Ma HT, Guo X, Wu WM, Gao EJ and
Zhao YH: lncRNA SNHG3 accelerates the proliferation and invasion of
non-small cell lung cancer by downregulating miR-340-5p. J Biol
Regul Homeost Agents. 34:2017–2027. 2020.PubMed/NCBI
|
|
37
|
Chen Z, Ying J, Shang W, Ding D, Guo M and
Wang H: miR-342-3p regulates the proliferation and apoptosis of
NSCLC cells by targeting BCL-2. Technol Cancer Res Treat.
20:153303382110411932021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li YY, Tao YW, Gao S, Li P, Zheng JM,
Zhang SE, Liang J and Zhang Y: Cancer-associated fibroblasts
contribute to oral cancer cells proliferation and metastasis via
Exosome-mediated paracrine miR-34a-5p. EBioMedicine. 36:209–220.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li LW, Xiao HQ, Ma R, Yang M, Li W and Lou
G: miR-152 is involved in the proliferation and metastasis of
ovarian cancer through repression of ERBB3. Int J Mol Med.
41:1529–1535. 2018.PubMed/NCBI
|
|
40
|
Chang DL, Wei W, Yu ZP and Qin CK:
miR-152-5p inhibits proliferation and induces apoptosis of liver
cancer cells by up-regulating FOXO expression. Pharmazie.
72:338–343. 2017.PubMed/NCBI
|
|
41
|
Reichenbach N, Delekate A, Plescher M,
Schmitt F, Krauss S, Blank N, Halle A and Petzold GC: Inhibition of
Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer's
disease model. EMBO Mol Med. 11:e96652019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu YX, Xu BW, Niu XD, Chen YJ, Fu XQ,
Wang XQ, Yin CL, Chou JY, Li JK, Wu JY, et al: Inhibition of
Src/STAT3 signaling-mediated angiogenesis is involved in the
anti-melanoma effects of dioscin. Pharmacol Res. 175:1059832022.
View Article : Google Scholar : PubMed/NCBI
|
